Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China flag China · Delayed Price · Currency is CNY
63.45
+0.38 (0.60%)
At close: Nov 17, 2026

Shanghai OPM Biosciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
822.13354.91297.24243.12294.37212.68
Revenue Growth
132.96%19.40%22.26%-17.41%38.41%70.19%
Gross Profit
382.41172.72154.9141.59187.12126.69
Operating Income
114.1522.456.4619.028955.6
Net Income
41.1441.721.0554.04105.3760.39
Earnings Per Share
0.310.370.180.471.040.70
EPS Growth
-15.66%105.56%-61.70%-54.81%48.57%415.84%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Culture Medium Products
300.45
CDMO
53.98
Total
354.44

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,2151,3471,3351,4841,717350.51
Total Debt
313.825765.3469.3991.8121.72
Net Cash (Debt)
901.651,2901,2701,4141,625228.79
Net Cash Growth
-31.32%1.55%-10.20%-12.96%610.20%-16.88%
Net Cash Per Share
6.7711.4410.8612.3016.042.65

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
196.09103.3969.2557.95111.62114.63
Capital Expenditures
-26.87-56.07-120.86-77.55-146.96-105.98
Free Cash Flow
169.2247.32-51.61-19.59-35.348.64
Free Cash Flow Growth
698.00%-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.51%48.67%52.11%58.24%63.57%59.56%
Operating Margin
13.88%6.33%2.17%7.82%30.23%26.14%
Pretax Margin
5.31%13.91%12.26%25.37%40.57%32.04%
Profit Margin
5.00%11.75%7.08%22.23%35.80%28.40%
FCF Margin
20.58%13.33%-17.36%-8.06%-12.01%4.06%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.4300.4300.4200.4400.429
Dividend Per Share Growth
-6.98%2.30%-4.47%2.66%-
Dividend Yield
0.68%0.88%1.15%0.80%0.58%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
205.38133.75197.05117.1880.29-
Forward PE
51.4955.2140.2364.15--
P/FCF Ratio
53.10117.85----
PS Ratio
10.9315.7113.9626.0428.74-